LOCALLY ADVANCED CERVICAL CANCER
Clinical trials for LOCALLY ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cervical cancer: volrustomig trial underway
Disease control OngoingThis study tests a drug called volrustomig in 30 women with advanced cervical cancer (stage IIIA to IVA) who have finished standard chemoradiation without their cancer getting worse. The goal is to see if volrustomig can help keep the cancer from returning or spreading. Participa…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
New drug combo shows promise against advanced cervical cancer in early trial
Disease control OngoingThis study tests whether adding the immunotherapy drug QL1706 to standard chemotherapy before surgery can improve outcomes for people with locally advanced cervical cancer. About 54 participants will receive the combination, then have surgery to remove the tumor. Researchers will…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC